Delivery Order SPE2DB20D1004-SPE2DB25FNEQK

Award Date 1/30/25
Potential Completion Date 1/31/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Forteo 600 mcg/2.4 ml pen injection medication. The contract has a ceiling value of $18,657.29 and a completion date of November 4, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the delivery of the pharmaceutical product Forteo 600 mcg/2.4 mL pen injector, with a ceiling value of $2,658.09 and a completion date of July 3, 2024. The contract is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31,...
This is a Delivery Order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Forteo 600 MCG/2.4 ML Pen Inj 2.4ML, a specialty pharmaceutical product. The contract has a ceiling value of $2,275.47 and a period of performance through March 4, 2025. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Forteo 600 mcg/2.4 ml pen injections and has a ceiling value of $18,452.80. It is a Firm Fixed Price delivery order contract with an ultimate completion date of October 25, 2024. This contract is not designated with a set-aside. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,532.19, is for the supply of 600 mcg/2.4 mL Forteo pen injections. The contract has a performance period through May 1, 2024 and is a firm fixed-price, delivery order type contract. The contract was awarded on an unrestricted basis with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of Forteo 600 mcg/2.4 ml pen injections, with a potential value of $5,316.18 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication, with a ceiling value of $8,666.46. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML. The contract has a ceiling value of $28,249.23 and a period of performance through January 31, 2025. The contract is a firm fixed price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,767.29, is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication. The contract has a firm fixed price and an ultimate completion date of March 5, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a $9,374.18 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Forteo 600 mcg/2.4 ml pen injection medication. The contract has an ultimate completion date of February 25, 2025 and was awarded on February 24, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNEQK
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the drug Forteo 600 mcg/2.4 ml pen injectable. The contract has a ceiling value of $2,977.19 and an ultimate completion date of January 31, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/4/25, 1:03 AM